This webinar will provide the evidence for PET imaging in medullary thyroid cancer according to the literature and the to international recommendations with a focus on the available radiopharmaceuticals and perspectives. Learning Objectives: The aim of this webinar is to understand and to learn the correct use of PET radiopharmaceuticals for staging and restaging medullary […]
This webinar will provide knowledge about hybrid imaging SPECT/ CT and PET/CT: CT acquisition protocol, added value of CACS and incidental findings on CTAC. Learning Objectives: The aim of the webinar is to: Faculty Registration Event Overview
The webinar will refresh the basics of full quantification and kinetics in nuclear neurology. Then some insights into new technologies and quantification will be given to the attendees. Learning Objectives: To improve the knowledge on the topic of full quantification in neurology and give the NM specialist the tools to think critically about the results. […]
Nuclear medicine is a quantitative imaging modality. However, its power and its vulnerabilities are not always appreciated. In this course, we will explore the formation of SPECT/CT and PET/CT imaging, and how, with corrections they can provide us with quantitative imaging biomarkers. We will look at different forms of quantification from kinetic modelling to activity concentration to SUV and explain how they can be used in a clinical environment. Finally, we will look at how scanner developments, software developments and Artificial Intelligence is influencing our field. In this course formal lectures will be supplemented with practical sessions and open discussions about Quantification in Nuclear Medicine.
This webinar will give an introduction into the GMP rules, basics and application to radiopharmaceutical productions. Learning Objectives: The aim of the webinar is to deliver the basic of GMP applied to radiopharmaceutical production. Faculty Registration Event Overview
Radiobiology is a branch of biology devoted to the study of biological effects of ionizing radiation on living organisms: we can speak about radiobiology in different clinical and research settings of Nuclear Medicine: dosimetry, preclinical and translational science, oncology, theranostics. With this webinar we will try to better understand the importance of this topic regarding […]
Early phase SPECT has the potential to expand the diagnosis spectrum of disphosphonate scintigraphy in non-oncologic situations. Incorporated in a clinical routine, it has the ability to focus the nuclear medicine physician attention on the most inflammatory lesions whichever they might be osseous, para-osseous ou extra-osseous. Our 1.5 day course is intended to be a […]
Radiolabelled prostate-specific membrane antigen (PSMA) is increasingly used for the diagnosis (i.e., staging and restaging) and treatment of patients with prostate cancer. Radionuclide PSMA therapy is a useful new treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC) and potentially also in patients with hormone-sensitive prostate cancer. The course will cover the spectrum of […]
Hybrid Imaging, SPECT/CT and PET/CT encompasses not only the well-known nuclear medicine cameras (Single Photon Emission Computed Tomography, SPECT and Positron Emission Tomography, PET) but also the CT-camera (Computed Tomography, CT), which can be used as a device to determine the attenuation of the radiation emitted from the radiopharmaceutical within the patient making it possible […]
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
